Honokiol
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Others |
Catalog number | BBF-03868 |
CAS | 35354-74-6 |
Molecular Weight | 541.6 |
Molecular Formula | C34H31N5O2 |
Purity | ≥98% |
Catalog Number | Size | Price | Stock | Quantity |
---|---|---|---|---|
BBF-03868 | 50 g | $457 | In stock |
Online Inquiry
Add to cartCapabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Honokiol is a polyphenol found in the genus Magnolia. Honokiol acts as an Akt inhibitor and also inhibits NF-κB, displaying anti-inflammatory, antiangiogenic and antitumor properties. It results in inhibition of bone metastatic growth of human prostate cancer cells. Honokiol has obvious antioxidant and anti-aging effects, thus can be used in cosmetic material. It is a plant polyphenol that can inhibit tyrosinase, block melanin synthesis, reduce skin pigment intensity, absorb UV, prevent photoaging, reduce sun damage and age spot formation, and whiten and lighten spots. It also has the anti-glycation effect, can effectively improve skin tone and skin texture, prevent the generation of age spots, remove red bloodlines, and improve skin blood microcirculation. It has the activity of antibacterial, anti-inflammatory, antioxidant, oil control, acne, promoting healing, and can be widely used in anti-acne, deodorization, acne and other products.
- Specification
- Properties
- Reference Reading
- Price Product List
- QC Data
Synonyms | Honokiol;35354-74-6;5,3'-Diallyl-2,4'-dihydroxybiphenyl;NSC 293100;3,5'-Diallyl-4,2'-dihydroxybiphenyl;3',5-Diallylbiphenyl-2,4'-diol;C18H18O2;3',5-diallyl-2,4'-biphenyldiol;CPD000387107;CHEMBL16901;2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol;CHEBI:5759;4-allyl-2-(3-allyl-4-hydroxy-phenyl)phenol;11513CCO0N;2-[4-hydroxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol;5,3'-Diallyl-biphenyl-2,4'-diol;MFCD00016674;NSC293100;[1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propenyl-;3',5-Di-2-propen-1-yl[1,1'-biphenyl]-2,4'-diol;NSC-293100;Honokiol,(S);2-(4-hydroxy-3-prop-2-enyl-phenyl)- 4-prop-2-enyl-phenol;(1P)-3',5-di(prop-2-en-1-yl)[1,1'-biphenyl]-2,4'-diol;3',5-(5,5'-)Diallyl-[1,1'-biphenyl]-2,4'-(2,2'-)diol;SMR000387107;3',5-di(prop-2-en-1-yl)biphenyl-2,4'-diol;Purinol;(1,1'-BIPHENYL)-2,4'-DIOL, 3',5-DI-2-PROPENYL-;UNII-11513CCO0N;Honokiol?;-dihydroxydiphenyl;3',5-diallyl-[1,1'-biphenyl]-2,4'-diol;Honokiol, HO;3',5-Di-2-propen-1-yl-[1,1'-biphenyl]-2,4'-diol; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propenyl- (9CI); 3',5-Diallyl-2,4'-biphenyldiol; Honokiol; NSC 293100;5,3′Honokiol - 95%;-Diallyl-2,4′FMLT BSASM H;HONOKIOL [MI];HONOKIOL [WHO-DD];Honokiol, analytical standard;cid_72303;MLS000759481;MLS001048916;MLS001423980;MLS006011755;SCHEMBL133034;REGID_for_CID_72303;GTPL11610;DTXSID30188845;3',1'-biphenyl)-2,4'-diol;HMS2051C12;HMS2271J07;HMS3393C12;HMS3656G03;(1,1'-BIPHENYL)-2,4'-DIOL, 3',5-DI-2-PROPEN-1-YL-;AMY40657;BCP28282;HY-N0003;AC-486;BBL027819;BDBM50157304;HB0328;s2310;STK801954;3'',5-diallylbiphenyl-2,4''-diol;Honokiol, >=98% (HPLC), powder;3,5'-diallyl-2',4-dihydroxybiphenyl;AKOS005622639;3',5-Diallyl-2,4'-dihydroxybiphenyl;CCG-100864;CS-1696;NC00114;5,3''-Diallyl-biphenyl-2,4''-diol;SMP2_000040;NCGC00163567-01;NCGC00163567-02;NCGC00163567-03;NCGC00163567-08;AS-15333;XH163752;5,3''''-Diallyl-biphenyl-2,4''''-diol;H1309;NS00011726;SW197494-3;EN300-7399522;A822747;SR-01000758208;Q-100425;Q5896650;SR-01000758208-5;{1,1'-Biphenyl]-2,4'-diol, 3,5-di-2-propenyl-;3'',5-di-2-propenyl-1,1''-biphenyl-2,4''-diol;BRD-K98493452-001-01-6;BRD-K98493452-001-14-9;Honokiol, European Pharmacopoeia (EP) Reference Standard;Z2065671480;[1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propen-1-yl;4-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-2-(prop-2-en-1-yl)phenol;InChI=1/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H;N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline; N-?(2-?Fluorophenyl)?-?5-?(6-?methyl-?2-?pyridinyl)?-?4-?[1,?2,?4]?triazolo[1,?5-?a]?pyridin-?6-?yl-1H-?imidazole-?2-?methanamine;Y4T; |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
IUPAC Name | 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol |
Canonical SMILES | C[C@@H](C1=CC2=CC=CC=C2C=C1)NC(=O)C3=C4C(=CC=C3)N=C(N4CCCC(=O)NC)C5=CN=CC6=CC=CC=C65 |
InChI | InChI=1S/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H2 |
InChI Key | FVYXIJYOAGAUQK-UHFFFAOYSA-N |
Appearance | White Solid |
Application | anti-inflammatory and anti-cancer agent |
Antibiotic Activity Spectrum | Gram-positive bacteria; neoplastics (Tumor) |
Boiling Point | 400.1°C at 760 mmHg |
Melting Point | 80-85°C |
Flash Point | 184°C |
Density | 1.107 g/cm3 |
Solubility | Soluble in DMSO (36 mg/mL) |
BBF-03488 | Streptozotocin | Inquiry |
BBF-01851 | Fumagillin | Inquiry |
BBF-02800 | DB-2073 | Inquiry |
BBF-03427 | Tubercidin | Inquiry |
BBF-03428 | Tubermycin B | Inquiry |
BBF-05818 | Docosahexaenoic acid | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
